NO122305B - - Google Patents
Download PDFInfo
- Publication number
- NO122305B NO122305B NO160901A NO16090165A NO122305B NO 122305 B NO122305 B NO 122305B NO 160901 A NO160901 A NO 160901A NO 16090165 A NO16090165 A NO 16090165A NO 122305 B NO122305 B NO 122305B
- Authority
- NO
- Norway
- Prior art keywords
- nicotinic acid
- mesoinositol
- product
- meso
- acid
- Prior art date
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- BIMKYWNFAXOBEQ-UHFFFAOYSA-N [2-hydroxy-3,4,5,6-tetrakis(pyridine-3-carbonyloxy)cyclohexyl] pyridine-3-carboxylate Chemical compound C=1C=CN=CC=1C(=O)OC1C(OC(=O)C=2C=NC=CC=2)C(OC(=O)C=2C=NC=CC=2)C(OC(=O)C=2C=NC=CC=2)C(O)C1OC(=O)C1=CC=CN=C1 BIMKYWNFAXOBEQ-UHFFFAOYSA-N 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 238000006386 neutralization reaction Methods 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 2
- 229960000367 inositol Drugs 0.000 claims 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 33
- 229960003512 nicotinic acid Drugs 0.000 description 15
- 235000001968 nicotinic acid Nutrition 0.000 description 15
- 239000011664 nicotinic acid Substances 0.000 description 15
- MFZCIDXOLLEMOO-UHFFFAOYSA-N inositol hexanicotinate Chemical compound C=1C=CN=CC=1C(=O)OC(C(C(OC(=O)C=1C=NC=CC=1)C(OC(=O)C=1C=NC=CC=1)C1OC(=O)C=2C=NC=CC=2)OC(=O)C=2C=NC=CC=2)C1OC(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- AZYXBPMPNIACAY-UHFFFAOYSA-N [Pb].C(C1=CN=CC=C1)(=O)O Chemical compound [Pb].C(C1=CN=CC=C1)(=O)O AZYXBPMPNIACAY-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1525164A SE321472C (sv) | 1964-12-15 | 1964-12-15 | Förfarande för framställning av en hydrolysprodukt av mycinositolhexanikotinat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO122305B true NO122305B (da) | 1971-06-14 |
Family
ID=20300379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO160901A NO122305B (da) | 1964-12-15 | 1965-12-14 |
Country Status (3)
| Country | Link |
|---|---|
| DK (1) | DK109139C (da) |
| NO (1) | NO122305B (da) |
| SE (1) | SE321472C (da) |
-
1964
- 1964-12-15 SE SE1525164A patent/SE321472C/xx unknown
-
1965
- 1965-12-14 NO NO160901A patent/NO122305B/no unknown
- 1965-12-15 DK DK643565AA patent/DK109139C/da active
Also Published As
| Publication number | Publication date |
|---|---|
| SE321472C (sv) | 1973-01-22 |
| DK109139C (da) | 1968-03-25 |
| SE321472B (sv) | 1970-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018158936A (ja) | β‐ヒドロキシ‐β‐メチル酪酸の精製方法 | |
| NO122305B (da) | ||
| Sato et al. | Azirines. II. The reaction of 2-phenylazirine with acylating agents | |
| NO134153B (da) | ||
| SU119529A1 (ru) | Способ получени роданина | |
| RU2662923C2 (ru) | Способ получения калия оротата | |
| SU72375A1 (ru) | Способ очистки 4-сульфоантраниловой кислоты | |
| EP0006784A2 (fr) | Nouveaux dérivés de la L-cystéine et leur application comme médicament, ainsi que procédé pour leur préparation | |
| US1977525A (en) | Manufacture of adenosine phosphoric acid | |
| US2006020A (en) | Process for preparing a substance derived from an amino aliphatic acid and phenylquinoline orthocarboxylic acid which is capable of lowering the uric acid level | |
| SU150832A1 (ru) | Способ получени 2,4-динитробензальдегида | |
| IL29324A (en) | New esters of 5-nitroimidazole-2-carboxylic acids and the process for their preparation | |
| SU67145A1 (ru) | Способ получени кристаллической глюкозы | |
| SU1736934A1 (ru) | Способ получени двузамещенного арсената олова (II) | |
| SU125553A1 (ru) | Способ получени хлоргидратов оксиалкилиминоэфиров 6-цианоалериановой кислоты | |
| SU715571A1 (ru) | Способ очистки глутаминовой кислоты | |
| DE322746C (de) | Verfahren zur Darstellung von Aethylidendiacetat | |
| SU65065A1 (ru) | Способ получени сахарина | |
| JPS617238A (ja) | ｄｌ−クロルプレナリンの光学分割法 | |
| SU130879A1 (ru) | Способ выделени молибдена из растворов, содержащих азотную и серную кислоты | |
| GB581944A (en) | Production of lithium hypochlorite | |
| SU810675A1 (ru) | Способ получени солей -лизина | |
| SU438638A1 (ru) | Способ получени солей -оксимасл ной кислоты | |
| NO762725L (no) | Fremgangsm}te og nye mellomprodukter for fremstilling av 6,11-dihydrodibenzo-(b.e.)-thiepin-11-one-3-eddiksyre | |
| SU451699A1 (ru) | Способ получени -хлориодпроизводных 2,4-хиназолиндиона |